Loading...
ATIM-07. STUDY OF PEMBROLIZUMAB, TUMOR TREATMENT FIELDS (OPTUNE®) AND TEMOZOLOMIDE FOR OLDER SUBJECTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Given the median age of diagnosis in glioblastoma is 65 years, a sizable proportion of cases occur in the elderly population. One of the most feared complications of radiation in elderly patients is cognitive decline due to radiation-induced neurotoxicity, which can be irreversible, extremely debili...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692257/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.103 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|